NYSE:BAX - Baxter International Stock Price, Price Target & More

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, July 17th. Stockholders of record on Friday, August 31st will be given a dividend of $0.19 per share on Monday, October 1st. This represents a $0.76 annualized dividend and a dividend yield of 1.02%. The ex-dividend date is Thursday, August 30th. View Baxter International's Dividend History.

Baxter International declared that its board has authorized a share repurchase plan on Wednesday, February 21st 2018, which permits the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) issued its quarterly earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.62 by $0.08. The medical instruments supplier earned $2.68 billion during the quarter, compared to analysts' expectations of $2.62 billion. Baxter International had a return on equity of 15.70% and a net margin of 7.75%. Baxter International's quarterly revenue was up 8.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.58 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Baxter International.

Baxter International updated its FY18 earnings guidance on Thursday, April, 26th. The company provided EPS guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.

16 brokerages have issued twelve-month price targets for Baxter International's stock. Their forecasts range from $62.00 to $83.00. On average, they anticipate Baxter International's stock price to reach $72.7333 in the next year. This suggests that the stock has a possible downside of 2.7%. View Analyst Ratings for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE) and Penumbra (PEN).

Press coverage about BAX stock has been trending somewhat positive on Thursday, according to Accern Sentiment. The research firm scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Baxter International earned a daily sentiment score of 0.13 on Accern's scale. They also assigned media headlines about the medical instruments supplier an impact score of 46.17 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Baxter International's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.25%), Bank of Montreal Can (0.11%), Gateway Investment Advisers LLC (0.08%), Boston Advisors LLC (0.07%), NN Investment Partners Holdings N.V. (0.05%) and Retirement Systems of Alabama (0.04%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Bank of Montreal Can, Assenagon Asset Management S.A., Ipswich Investment Management Co. Inc., Westpac Banking Corp, Gateway Investment Advisers LLC, Tokio Marine Asset Management Co. Ltd. and Meag Munich Ergo Kapitalanlagegesellschaft MBH. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including Sit Investment Associates Inc., Handelsbanken Fonder AB, Boston Advisors LLC, Calamos Advisors LLC, Municipal Employees Retirement System of Michigan, Gulf International Bank UK Ltd, State of Alaska Department of Revenue and Fjarde AP Fonden Fourth Swedish National Pension Fund. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $74.74.

Baxter International has a market capitalization of $40.03 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]